Treatment of Severe Alcoholic Hepatitis
For severe alcoholic hepatitis, prednisolone 40 mg daily for 28 days is the recommended first-line treatment for patients with Maddrey Discriminant Function (MDF) >32 or MELD score >20, with treatment response assessed at day 7 using the Lille model. 1
Disease Severity Assessment
- Severity should be determined using validated scoring systems:
- Maddrey Discriminant Function (MDF) >32
- MELD score >20 (optimal benefit with MELD 25-39) 2
- Glasgow Alcoholic Hepatitis Score ≥9
- ABIC score category C
First-Line Treatment
Corticosteroid Therapy
- Prednisolone 40 mg daily orally for 28 days for patients with severe alcoholic hepatitis 1, 3
- Response assessment at day 7 using:
- Lille model (optimal cutoff: <0.45 indicates response)
- Early Change in Bilirubin Level (ECBL)
- Response classification 3:
- Complete responders (Lille ≤0.16): continue prednisolone
- Partial responders (Lille 0.16-0.56): continue prednisolone
- Null responders (Lille ≥0.56): discontinue steroids and consider liver transplantation
Contraindications to Corticosteroids
- Uncontrolled infection
- Gastrointestinal bleeding
- Renal failure
- Pancreatitis
- Hepatitis B viral infection
- Tuberculosis
Alternative Treatments
- N-acetylcysteine + corticosteroids can be considered as it shows short-term benefit 1
- Pentoxifylline is no longer recommended as an alternative to steroids due to ineffectiveness 1, 4
Emerging Therapies
- Fecal microbiota transplantation (FMT) has shown promise in recent research:
Supportive Care
- Complete alcohol abstinence is critical for survival 1, 3
- Nutritional support:
- Protein intake: 1.2-1.5 g/kg/day
- Caloric intake: 35-40 kcal/kg/day
- Consider enteral feeding if patient cannot eat 3
- Vitamin and mineral supplementation (vitamin A, thiamine, B12, folate, pyridoxine, vitamin D, zinc) 1
- Infection screening before initiating corticosteroids:
- Blood cultures
- Urine cultures
- Ascites fluid cultures if present 1
Liver Transplantation
- Consider early liver transplantation for carefully selected patients who:
Monitoring and Complications
- Avoid nephrotoxic drugs, including diuretics 3
- Monitor for development of infections, which increase mortality risk 1
- Watch for hepatorenal syndrome, an early manifestation of multi-organ failure 3
Important Caveats
- The benefit of corticosteroids is modest and limited to 28 days, with no improvement in long-term survival 3
- Patients with MELD >51 do not benefit from corticosteroids 2
- Infection risk is significantly higher with prednisolone (13%) compared to no prednisolone (7%) 4
- Long-term outcomes depend primarily on maintaining abstinence from alcohol 1